16 October 2025, Rome – From 14 to 16 October Rome hosts the General Assembly of Biomedical Research, promoted by the Italian Ministry of Universities and Research and the Ministry of Health, under the patronage of the European Commission. The initiative aims to foster dialogue among the scientific community, the healthcare system, industry, and public institutions, promoting evidence-based public policies and shaping a shared vision for the future of biomedical research in Italy.
The event included remarks from President of the Italian Republic Sergio Mattarella and the attendance of Italy’s highest State authorities, together with European Commissioner for Startups, Research and Innovation Ekaterina Zaharieva. Other distinguished guests include, Nobel Laureate Sir Paul Nurse, author of the Research and Innovation Organisation Landscape report for the United Kingdom, who delivered the keynote speech.
The three-day event focuses on three major themes. The first concerns the transition from basic to applied research, with the goal of strengthening collaboration between academia and industry and enhancing technology transfer. The second will address emerging technologies, exploring the transformative role of artificial intelligence, genomics, personalized medicine, and digital health. Finally, the third theme will center on skills and internationalization, aiming to bridge the gap between advanced training and labor market needs, while also attracting top talent and leveraging European-funding opportunities.
The discussion addresses crosscutting as a prevention method, which is a crucial yet often overlooked area for ensuring the long-term sustainability of healthcare systems through research and public awareness.
To encourage active participation, a call for papers invites young researchers (under 40) to submit contributions on innovative approaches to biomedical research. The most significant papers will be featured in the forthcoming White Paper on Biomedical Research — a government-issued strategic document that presents key analyses, policy directions, and proposals to guide future national research policies and funding priorities, jointly curated by the Italian Ministry of Universities and Research and the Italian Ministry of Health.
Within this strategic forum, the National Center for Gene Therapy and Drugs Based on RNA Technology took a leading role during the final day of the event in the session titled National Recovery and Resilience Plan (PNRR): Opportunities and Sustainability.
